Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SOLIGENIX, INC. Director's Dealing 2009

Jul 9, 2009

35119_dirs_2009-07-09_d2db2d9d-c78f-4634-909f-d8a33a3e1997.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-07-01

Reporting Person: SCHNITTKER CHRISTOPHER P (VP ADMIN CONTROLLER)

More from SOLIGENIX, INC.

Regulatory Filings 2026
May 28
Capital/Financing Update 2026
May 28
Interim / Quarterly Report 2026
May 8
Interim / Quarterly Report 2026
May 8
Interim / Quarterly Report 2026
May 8
Capital/Financing Update 2026
May 8
Interim / Quarterly Report 2026
May 8
Regulatory Filings 2026
Apr 28
Regulatory Filings 2026
Apr 3
Regulatory Filings 2026
Apr 3
View all filings →